Bert Bravenboer

6.6k total citations · 1 hit paper
107 papers, 3.4k citations indexed

About

Bert Bravenboer is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Bert Bravenboer has authored 107 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 24 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Epidemiology. Recurrent topics in Bert Bravenboer's work include Pain Mechanisms and Treatments (15 papers), Neurological Disorders and Treatments (11 papers) and Thyroid Disorders and Treatments (9 papers). Bert Bravenboer is often cited by papers focused on Pain Mechanisms and Treatments (15 papers), Neurological Disorders and Treatments (11 papers) and Thyroid Disorders and Treatments (9 papers). Bert Bravenboer collaborates with scholars based in Netherlands, Belgium and United States. Bert Bravenboer's co-authors include Brigitte Velkeniers, D.W. Erkelens, Willem Hendrik Gispen, A.C. Kappelle, P. Sytze van Dam, Jeroen de Filette, Geert Jan Biessels, Coen D.A. Stehouwer, Corina Andreescu and Filip Cools and has published in prestigious journals such as The Lancet, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Bert Bravenboer

101 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors

2019 253 citations Jeroen de Filette, Corina Andreescu et al. Hormone and Metabolic Research profile →

Peers

Countries citing papers authored by Bert Bravenboer

Since Specialization

Citations

This map shows the geographic impact of Bert Bravenboer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Bravenboer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Bravenboer more than expected).

Fields of papers citing papers by Bert Bravenboer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Bravenboer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Bravenboer. The network helps show where Bert Bravenboer may publish in the future.

Co-authorship network of co-authors of Bert Bravenboer

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Bravenboer. A scholar is included among the top collaborators of Bert Bravenboer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Bravenboer. Bert Bravenboer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of COVID-19 on Physical Activity, Fatigue, and Frailty in Community-Dwelling Older Adults: A Cross-Sectional Study 2023 ·Journal of Aging and Physical Activity ·Veerle Knoop, (unknown), Aziz Debain, (unknown), Patricia De Vriendt, Ellen Gorus, Bert Bravenboer, Bart Jansen, Aldo Scafoglieri, Ivan Bautmans, (unknown)	1
2	Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review 2023 ·Journal of Oncology Pharmacy Practice ·(unknown), (unknown), (unknown), Bert Bravenboer, Sandrine Aspeslagh	1
3	Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms 2022 ·BMC Endocrine Disorders ·Jeroen de Filette, S. André, (unknown), Sandrine Aspeslagh, Rafik Karmali, Bart Van Der Auwera, Bert Bravenboer	4
4	Value of [11C]-Methionine PET/CT in Preoperative Localization of Parathyroid Adenomas 2021 ·Hormone and Metabolic Research ·(unknown), Brigitte Velkeniers, Marleen Keyaerts, (unknown), Marian Vanhoeij, (unknown), Bert Bravenboer	2
5	Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer: a retrospective study 2021 ·Thyroid Research ·(unknown), Bert Bravenboer, Brigitte Velkeniers, (unknown), Marleen Keyaerts, Corina Andreescu	2
6	Pharmacologic Treatment for Hypoactive Delirium in Adult Patients: A Brief Report of the Literature 2021 ·Journal of the American Medical Directors Association ·(unknown), Aziz Debain, Siddhartha Lieten, Bert Bravenboer, Tony Mets	3
7	Body composition as determinant of thrombin generation in plasma. The Hoorn study 2010 ·Research Online (University of Wollongong) ·(unknown), Isabel Ferreira, Henri M.H. Spronk, Bert Bravenboer, Joost Dekker, G. Nijpels, Hugo Ten Cate, Coen D.A. Stehouwer	1
8	High prevalence of diabetes mellitus in patients with liver cirrhosis 2010 ·Diabetic Medicine ·Nick Wlazlo, (unknown), Erik J. Schoon, H.P. Sauerwein, Coen D.A. Stehouwer, Bert Bravenboer	39
9	Abacavir/Lamivudine/Zidovudine Maintenance After Standard Induction in Antiretroviral Therapy-Naïve Patients: FREE Randomized Trial Interim Results 2010 ·AIDS Patient Care and STDs ·Herman G. Sprenger, (unknown), Paul Mulder, Chris H.H. ten Napel, (unknown), Andy I. M. Hoepelman, (unknown), Peter P. Koopmans, M.E.E. van Kasteren, Bert Bravenboer, Reinier W. ten Kate, P. H. P. Groeneveld, Tjip S. van der Werf, Elisabeth H. Gisolf, Clemens Richter	4
10	Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity‐onset diabetes of the young 2009 ·Diabetic Medicine ·(unknown), Monique Losekoot, Roelof J. Odink, Bert Bravenboer	5
11	Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy 2008 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Meta Michels, Fred C.G.J. Sweep, Ad R. Hermus, (unknown), David M. Burger, Bert Bravenboer, Peter P. Koopmans, André van der Ven	149
12	Atrial natriuretic peptide–induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients 2002 ·American Journal of Kidney Diseases ·Gerald Vervoort, Jack F.M. Wetzels, Jos A. Lutterman, Bert Bravenboer, Jo H. M. Berden, Paul Smits	17
13	Congenital hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene. 1996 ·The Journal of Clinical Endocrinology & Metabolism ·Hennie Bikker, J. J. J. Waelkens, Bert Bravenboer, J J de Vijlder	45
14	Effects of α-lipoic acid and glutathione on systemic and sciatic nerve antioxidant levels in experimental diabetes 1995 ·Utrecht University Repository (Utrecht University) ·W.H. Gispen, P. Sytze van Dam, B. Sweder van Asbeck, Bert Bravenboer, Johannes F.L.M. van Oirschot, (unknown)	1
15	The effect of diabetes mellitus on development of autonomic neuropathy in the rat: Beneficial effects of the ACTH4-9 analogue Org 2766 on existing diabetic neuropathy 1994 ·Data Archiving and Networked Services (DANS) ·W.H. Gispen, A.C. Kappelle, Geert Jan Biessels, (unknown), Bert Bravenboer, Dick J. De Wildt	6
16	Subclinical diabetic polyneuropathy: early detection of involvement of different nerve fibre types. 1993 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), P. Liam Oey, G.H. Wieneke, Bert Bravenboer, A.C. van Huffelen	38
17	Relationships between dyspeptic symptoms and gastrointestinal motility in patients with Type 1 (insulin-dependent) diabetes mellitus 1993 ·Diabetologia ·H. J. A. Jebbink, Bert Bravenboer, L. M. A. Akkermans, (unknown), Andreas J. Smout	37
18	ACTH4–9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats 1993 ·Acta Diabetologica ·Bert Bravenboer, A.C. Kappelle, (unknown), D.W. Erkelens, Willem Hendrik Gispen	25
19	The Ca2+ antagonist nimodipine counteracts the onset of an experimental neuropathy in streptozotocin induced, diabetic rats 1992 ·Neuroscience Research Communications ·W.H. Gispen, A.C. Kappelle, Bert Bravenboer, J. Traber, D.W. Erkelens	17
20	Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat 1992 ·Diabetologia ·Bert Bravenboer, A.C. Kappelle, Frank P.T. Hamers, (unknown), D.W. Erkelens, Willem Hendrik Gispen	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact